Tokyo, Oct. 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063230) titled 'Effectiveness and safety of continuous low-dose (10 mg/day) finerenone administration in patients with type 2 diabetes and chronic kidney disease' on Oct. 9.
Study Type:
Observational
Primary Sponsor:
Institute - Edogawa Hospital
Condition:
Condition - Patients with type 2 diabetes and chronic kidney disease.
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the clinical effectiveness (changes in urinary albumin-to-creatinine ratio and estimated glomerular filtration rate) and safety (changes in serum potassium levels) of continuous low-dose (10 mg/day) ...